FDA Clears Ustekinumab (Stelara) for Plaque Psoriasis in Teens

For at least two thirds of patients aged 12 to 17 years who were treated with ustekinumab, cleared skin or minimal psoriasis was achieved at week 12 in a phase 3 study.
FDA Approvals

http://ift.tt/2zdmmUL